Oxidized Phospholipid-Induced Inflammation in Atherosclerosis

动脉粥样硬化中氧化磷脂诱发的炎症

基本信息

  • 批准号:
    7082696
  • 负责人:
  • 金额:
    $ 34.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis is a chronic inflammatory disease, characterized by specific infiltration of monocytic cells, such as monocytes and T-cells, while neutrophils are essentially absent in the fatty streak lesion. One of the earliest steps in the development of the atherosclerotic lesion is the adhesion of monocytes to endothelial cells of the vessel wall. Previously it was demonstrated that, if stimulated with minimally modified LDL (MM-LDL), endothelial cells are activated to specifically bind monocytes, but not neutrophils. This specificity towards mononuclear cells was subsequently observed with the activation of endothelial cells by oxidized 1-palmitoyl-2-arachidonoyl-s/7-glycero-3-phosphocholine (OxPAPC), implying lipid oxidation products as culprits in chronic inflammation. We hypothesize that specific phospholipid oxidation products (OxPL) trigger vascular inflammation and determine monocyte specificity characteristic of atherosclerosis and other chronic inflammatory diseases. The outcome of the proposed studies will add to our understanding of how atherosclerosis is initiated and propagated and should lead to new strategies in the treatment of chronic inflammatory disorders. The specific aims addressed in this proposal are: Specific Aim #1: To structurally identify individual OxPL that determine monocyte specific inflammation and to investigate the hypothesis that OxPL-induced signaling involves TLR4. We will investigate intracellular signaling pathways induced by OxPL that lead to specific monocyte adhesion in vitro, using HUVEC as well as isolated murine aortic EC. Furthermore, we will test the hypothesis that POVPC is one active component in OxPAPC that determines monocyte specificity and determine structure-function relationships. We will examine the role of TLR-4 and the involvement of the TLR-4 adaptor proteins MyD88 and TRIP, as well as respective downstream elements in OxPL-mediated signalling events. Specific Aim #2: To explore the hypothesis that OxPL are triggers of vascular inflammation in vivo. To mimic accumulation of OxPL in the vascular wall, we will topically apply OxPL to carotid arteries in mice and measure chemokine and adhesion molecule expression. Furthermore, we will use ex vivo perfused carotid arteries to study OxPL-induced monocyte rolling and adhesion. Specific Aim #3: To examine the hypothesis that OxPL-induced specific mononuclear cell accumulation in vivo requires a specific chemokine expression pattern and involves 12 lipoxygenase. Using the mouse air pouch model, we will examine OxPL-induced leukocyte accumulation in vivo and characterize leukocyte subsets. We will investigate the chemokine expression pattern as well as time course of expression in OxPL-induced compared to LPS-induced inflammation. Furthermore, we will investigate the role of 12-LO in OxPL-induced inflammation in vivo.
描述(由申请人提供):动脉粥样硬化是一种慢性炎性疾病,其特征在于单核细胞(如单核细胞和T细胞)的特异性浸润,而嗜中性粒细胞在脂肪条纹病变中基本上不存在。动脉粥样硬化病变发展的最早步骤之一是单核细胞与血管壁内皮细胞的粘附。以前证明,如果用最低修饰的LDL(MM-LDL)刺激,内皮细胞被激活以特异性结合单核细胞,但不结合中性粒细胞。随后通过氧化的1-棕榈酰-2-花生四烯酸-S/7-甘油-3-磷酸胆碱(OxPAPC)激活内皮细胞观察到对单核细胞的这种特异性,这意味着脂质氧化产物是慢性炎症的罪魁祸首。我们假设,特定的磷脂氧化产物(OxPL)触发血管炎症,并确定动脉粥样硬化和其他慢性炎症性疾病的单核细胞特异性特征。这些研究的结果将增加我们对动脉粥样硬化是如何开始和传播的理解,并将导致慢性炎症性疾病治疗的新策略。该提案的具体目标是: 具体目标1:从结构上鉴定决定单核细胞特异性炎症的单个OxPL,并研究OxPL诱导的信号传导涉及TLR 4的假设。我们将研究细胞内信号转导途径诱导OxPL导致特异性单核细胞粘附在体外,使用HUVEC以及分离的小鼠主动脉EC。此外,我们将测试的假设,POVPC是一个活性成分的OxPAPC,决定单核细胞特异性和确定结构-功能关系。我们将研究TLR-4的作用和TLR-4衔接蛋白MyD 88和TRIP的参与,以及OxPL介导的信号传导事件中各自的下游元件。 具体目标#2:探索OxPL是体内血管炎症触发因素的假设。为了模拟OxPL在血管壁中的积累,我们将OxPL局部应用于小鼠的颈动脉并测量趋化因子和粘附分子的表达。此外,我们将使用离体灌注的颈动脉来研究OxPL诱导的单核细胞滚动和粘附。 具体目标#3:为了检验假设,OxPL诱导的特异性单核细胞在体内的积累需要一个特定的趋化因子的表达模式,并涉及12脂氧合酶。使用小鼠气囊模型,我们将检查OxPL诱导的体内白细胞蓄积并表征白细胞亚群。我们将研究趋化因子的表达模式,以及表达的时间过程中OxPL诱导相比,LPS诱导的炎症。此外,我们将研究12-LO在OxPL诱导的体内炎症中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NORBERT LEITINGER其他文献

NORBERT LEITINGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NORBERT LEITINGER', 18)}}的其他基金

Acetyl CoA Carboxylase in the Metabolic Control of Inflammation
乙酰辅酶A羧化酶在炎症代谢控制中的作用
  • 批准号:
    10660439
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
Metabolic adaption of macrophages to heme detoxification in systemic vascular inflammation
巨噬细胞对全身血管炎症中血红素解毒的代谢适应
  • 批准号:
    10705347
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
Pannexin 1 channels in diet-induced metabolic syndrome
Pannexin 1 通道在饮食诱导的代谢综合征中的作用
  • 批准号:
    10200124
  • 财政年份:
    2014
  • 资助金额:
    $ 34.14万
  • 项目类别:
Pannexin 1 channels in diet-induced metabolic syndrome
Pannexin 1 通道在饮食诱导的代谢综合征中的作用
  • 批准号:
    10625332
  • 财政年份:
    2014
  • 资助金额:
    $ 34.14万
  • 项目类别:
Pannexin 1 channels in diet-induced metabolic syndrome
Pannexin 1 通道在饮食诱导的代谢综合征中的作用
  • 批准号:
    10407615
  • 财政年份:
    2014
  • 资助金额:
    $ 34.14万
  • 项目类别:
Role of Dab2 in Fatty Liver Disease
Dab2 在脂肪肝疾病中的作用
  • 批准号:
    8828681
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Role of Dab2 in Fatty Liver Disease
Dab2 在脂肪肝疾病中的作用
  • 批准号:
    8505654
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Role of Dab2 in Fatty Liver Disease
Dab2 在脂肪肝疾病中的作用
  • 批准号:
    8649037
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Role of Dab2 in Fatty Liver Disease
Dab2 在脂肪肝疾病中的作用
  • 批准号:
    9043060
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Oxidized Phospholipid-Induced Inflammation in Atherosclerosis
动脉粥样硬化中氧化磷脂诱发的炎症
  • 批准号:
    7391240
  • 财政年份:
    2006
  • 资助金额:
    $ 34.14万
  • 项目类别:

相似海外基金

How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
  • 批准号:
    DP240103141
  • 财政年份:
    2024
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
  • 批准号:
    MR/X00029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
  • 批准号:
    2312378
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
  • 批准号:
    23K06408
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
  • 批准号:
    10680969
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
  • 批准号:
    10744556
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
  • 批准号:
    23K06597
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
  • 批准号:
    23K05034
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
  • 批准号:
    2838427
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
  • 批准号:
    10827567
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了